Principal Financial Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-671
Closed -$6.97K 2214
2024
Q3
$6.97K Sell
671
-758
-53% -$12.6K ﹤0.01% 2220
2024
Q2
$28.1K Sell
1,429
-522
-27% -$10.5K ﹤0.01% 2322
2024
Q1
$50K Buy
1,951
+286
+17% +$7.33K ﹤0.01% 2346
2023
Q4
$46K Sell
1,665
-222
-12% -$13.5K ﹤0.01% 2336
2023
Q3
$115K Sell
1,887
-33
-2% -$2.32K ﹤0.01% 2260
2023
Q2
$126K Buy
1,920
+352
+22% +$25.8K ﹤0.01% 2255
2023
Q1
$99.7K Buy
1,568
+280
+22% +$32K ﹤0.01% 2299
2022
Q4
$178K Buy
1,288
+146
+13% +$20.6K ﹤0.01% 2221
2022
Q3
$144K Buy
1,142
+228
+25% +$25.8K ﹤0.01% 2266
2022
Q2
$76K Buy
914
+199
+28% +$15.4K ﹤0.01% 2425
2022
Q1
$69K Sell
715
-9,654
-93% -$1.27M ﹤0.01% 2466
2021
Q4
$2.07M Sell
10,369
-23,797
-70% -$5.62M ﹤0.01% 1849
2021
Q3
$8.46M Buy
34,166
+1,052
+3% +$301K 0.01% 1485
2021
Q2
$13.7M Buy
33,114
+11,935
+56% +$4.73M 0.01% 1249
2021
Q1
$8.27M Buy
21,179
+12,322
+139% +$6.07M 0.01% 1476
2020
Q4
$4.96M Buy
8,857
+213
+2% +$135K ﹤0.01% 1564
2020
Q3
$6.04M Sell
8,644
-61
-0.7% -$47.6K 0.01% 1366
2020
Q2
$6.88M Buy
8,705
+4,515
+108% +$3.4M 0.01% 1274
2020
Q1
$2.5M Sell
4,190
-54
-1% -$52.6K ﹤0.01% 1538
2019
Q4
$4.82M Sell
4,244
-127
-3% -$138K ﹤0.01% 1543
2019
Q3
$5.2M Sell
4,371
-163
-4% -$249K ﹤0.01% 1502
2019
Q2
$7.47M Buy
4,534
+1,300
+40% +$2.25M 0.01% 1383
2019
Q1
$6.59M Buy
3,234
+210
+7% +$370K 0.01% 1449
2018
Q4
$3.89M Sell
3,024
-185
-6% -$284K ﹤0.01% 1582
2018
Q3
$6.07M Sell
3,209
-212
-6% -$438K 0.01% 1541
2018
Q2
$6.96M Sell
3,421
-2,118
-38% -$4.83M 0.01% 1491
2018
Q1
$12.3M Sell
5,539
-17
-0.3% -$43.2K 0.01% 1131
2017
Q4
$12.8M Buy
5,556
+215
+4% +$436K 0.01% 1114
2017
Q3
$9.5M Buy
5,341
+1,828
+52% +$2.55M 0.01% 1273
2017
Q2
$4.78M Buy
3,513
+1,782
+103% +$2.15M ﹤0.01% 1563
2017
Q1
$2.04M Sell
1,731
-6
-0.3% -$6.12K ﹤0.01% 1726
2016
Q4
$1.39M Buy
1,737
+95
+6% +$75.4K ﹤0.01% 1768
2016
Q3
$1.44M Buy
1,642
+89
+6% +$64.5K ﹤0.01% 1718
2016
Q2
$870K Sell
1,553
-32
-2% -$18.1K ﹤0.01% 1775
2016
Q1
$872K Hold
1,585
﹤0.01% 1749
2015
Q4
$1.32M Sell
1,585
-3
-0.2% -$3K ﹤0.01% 1713
2015
Q3
$1.76M Sell
1,588
-410
-21% -$748K ﹤0.01% 1676
2015
Q2
$4.36M Sell
1,998
-1,896
-49% -$3.86M 0.01% 1465
2015
Q1
$6.09M Buy
3,894
+44
+1% +$58.1K 0.01% 1283
2014
Q4
$4.57M Sell
3,850
-231
-6% -$154K 0.01% 1422
2014
Q3
$1.9M Buy
4,081
+44
+1% +$20.3K ﹤0.01% 1658
2014
Q2
$2.02M Buy
4,037
+69
+2% +$22.1K ﹤0.01% 1680
2014
Q1
$1.17M Buy
3,968
+39
+1% +$11.8K ﹤0.01% 1753
2013
Q4
$1.07M Buy
3,929
+69
+2% +$19.3K ﹤0.01% 1765
2013
Q3
$1.35M Buy
+3,860
New +$1.43M ﹤0.01% 1707

Other funds holding BLUE

Principal Financial Group's BLUE Position: Q4 2024 in Review

Principal Financial Group sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 671 shares — an estimated $6.97K sold.

Principal Financial Group first reported a position in BLUE in Q3 2013 and held it in 45 quarters. The position peaked at $13.7M in Q2 2021. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Principal Financial Group reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Principal Financial Group sold 671 bluebird bio shares in Q4 2024, an estimated $6.97K.
  • Principal Financial Group first reported a position in bluebird bio in Q3 2013 and held it in 45 quarters.
  • Principal Financial Group's bluebird bio position peaked at $13.7M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Principal Financial Group's 13F filing for Q4 2024, filed 31 Jan 2025.